Methotrexate (MTX) is a cornerstone in the treatment of inflammatory arthritis owing to its immunomodulatory effects. Its use has expanded to the management of post-viral inflammatory conditions, including chronic arthritis caused by Chikungunya virus (CHIKV) infection, which may mimic rheumatoid arthritis (RA)
1. Although effective, MTX poses a risk of adverse effects, including rare but potentially life-threatening complications such as pneumonitis
2,3.